Large, drooping breasts are the hardest case for an implant reconstruction done at the same time as a mastectomy. There is too much skin, and the nipple sits too low. Skin-reducing mastectomy deals with both in one operation. This article explains how it works, what the published results show, and which patients it suits.
In short
- The breast tissue and the extra skin are removed in one operation, using the same anchor-shaped cuts as a breast reduction.
- A layer of the patient’s own skin is kept inside to protect the lower part of the implant.
- The weak point is where the scars meet, called the T-junction.
- Results improved as surgeons refined the technique and chose patients more carefully.
- The evidence comes from small series in single hospitals, so its overall quality is low.
How it works
Nava and colleagues in Milan described the operation in 2006, for breasts with more than 8 cm between the areola and the fold under the breast.1
The kept layer of skin is called the dermal flap. It is living tissue with its own blood supply. If the scar above it opens, the implant is still covered.
The top of the implant can be covered by the chest muscle, or by a matrix when the implant sits on top of the muscle. Surgeons have published many versions. A 2018 review counted nine families of them.7
What the studies found
The first report was honest about the risks. In 30 procedures, 4 reconstructions (13%) lost skin badly enough that the implant had to be removed.1
Later reports did better. Colizzi and colleagues in Pisa changed how the flap is attached, in 22 procedures.2 Bonomi and colleagues in Milan reported 62 procedures with a dermal flap and an absorbable mesh. Results were good to excellent in 92.8%, and 84% of patients were very or highly satisfied. Higher body mass index was the strongest risk factor for complications.3
In a 2025 series of 20 patients with no mesh or matrix, slow healing at the T-junction was the most common problem, and no implant was lost.4 Patients expected to need radiotherapy were not included.
With a bovine pericardium matrix
Two sources describe the operation with ExaShape®. A 2023 congress poster reported 30 breasts with a mean mastectomy weight of 985 g. Five breasts (16.6%) had a complication and no implant was removed.5 A poster has not been through peer review.
In the Riccio 2026 study, all 56 patients had the anchor-shaped cuts and 78.5% had ExaShape. 94.6% of implants were kept.6 The paper reports results for the whole group, not by matrix.
Who it suits
For patients at higher risk, a two-stage reconstruction may be safer. See mastectomy flap necrosis: risk assessment and radiotherapy and implant reconstruction.
There is also an alternative that avoids the anchor-shaped cuts. A 2025 series of 62 patients with breasts up to 799 g kept the skin and placed the implant on top of the muscle. 37% had rippling or a small contour problem, and 29% had fat grafting.8
Most of these patients also need the other breast reduced or lifted. Doing that in the same operation did not raise complications in a 2025 pooled analysis, although most of those patients had reconstruction with their own tissue.9
What it means in practice
Skin-reducing mastectomy does not suit everyone with large breasts. In a well-chosen patient, it removes the cancer, reduces the skin and rebuilds the breast in one operation, with her own skin protecting the implant where it is most exposed.
References
- Nava MB, Cortinovis U, Ottolenghi J, et al. Skin-reducing mastectomy. Plast Reconstr Surg. 2006;118(3):603-610. doi:10.1097/01.prs.0000233024.08392.14
- Colizzi L, Lazzeri D, Agostini T, et al. Skin-reducing mastectomy: new refinements. J Plast Surg Hand Surg. 2010;44(6):296-301. doi:10.3109/2000656X.2010.517681
- Bonomi S, Sala L, Gennaro M, Ricci C, Cortinovis U. Skin-reducing mastectomy and direct-to-implant breast reconstruction with submuscular-dermal-mesh pocket. Ann Plast Surg. 2019;82(1):19-27. doi:10.1097/SAP.0000000000001614
- Abdelmageed AE, Awad AT, El-Fayoumi TA, et al. Skin-reducing mastectomy and direct-to-implant breast reconstruction without mesh: a single-institute experience. Cureus. 2025;17(3):e81417. doi:10.7759/cureus.81417
- Varvaras D, Sachoulidou A, De Felice V, et al. Skin-reducing mastectomy and immediate hybrid breast reconstruction using acellular pericardium matrix and de-epithelialized dermal flap in medium and large hypertrophic and ptotic breasts. Poster, St. Gallen International Breast Cancer Conference; 2023.
- Riccio M, Zingaretti N, Aquinati A, et al. Oncoaesthetic breast reconstruction after mastectomy improves patient satisfaction and aesthetic outcomes. Clin Breast Cancer. 2026;26(10):134-146. doi:10.1016/j.clbc.2026.08.025
- Hansson E, Jepsen C, Hallberg H. Breast reconstruction with a dermal sling: a systematic review of surgical modifications. J Plast Surg Hand Surg. 2019;53(1):1-13. doi:10.1080/2000656X.2018.1533840
- Salgarello M, Fabbri M, Visconti G, et al. Immediate breast reconstruction with prepectoral polyurethane-covered implant after conservative mastectomy in large and ptotic breasts. Aesthetic Plast Surg. 2025;49(23):6555-6564. doi:10.1007/s00266-025-05070-w
- Wang CY, Montalmant KE, Peng T, et al. The safety of simultaneous versus delayed contralateral breast symmetrization: systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2025;105:348-358. doi:10.1016/j.bjps.2025.04.023
Important information This article is general education, not medical advice. Tap to read the full medical, regulatory & legal notice.
This article is provided by Advanced Biomedical Concept for general informational and educational purposes only. It does not constitute medical, surgical, diagnostic, or other professional healthcare advice, and it is not a substitute for consultation with a suitably qualified healthcare professional. Reading it creates no doctor–patient or other professional relationship. Nothing here should be used to diagnose, treat, cure, or prevent any disease or condition, or to make decisions about medical care. Always seek the advice of a physician or other qualified provider with any questions about a medical condition or treatment, and never disregard or delay professional advice because of something you have read here.
Any reference to Advanced Biomedical Concept products (including ExaShape and ExaFat) is provided for general information only. These are medical devices intended to be used by appropriately trained healthcare professionals strictly in accordance with their applicable, current Instructions for Use (IFU). Regulatory status (including CE marking and classification under the EU Medical Device Regulation), market availability, and approved indications differ between countries and may change over time; a device referred to here may not be available or approved in your country. This content is not intended as, and must not be relied upon as, a statement or claim of safety, clinical performance, or efficacy beyond what is set out in the applicable IFU and current regulatory approvals. Product-specific information is directed at healthcare professionals and is not intended to promote, advertise, or offer any medical device to the general public where such promotion is restricted or prohibited by law.
Statements reflect information believed to be accurate at the date of publication and may be updated or corrected without notice. Any statements regarding the future are expectations or general views, not guarantees. Clinical outcomes depend on many individual factors, results vary from person to person, and no particular result is promised or implied. Where third-party studies, sources, or external links are referenced, they are provided for convenience and information only and do not imply endorsement, and Advanced Biomedical Concept is not responsible for their content.
To the fullest extent permitted by applicable law, Advanced Biomedical Concept and its officers, employees, contributors, and representatives (each acting in that capacity and on behalf of Advanced Biomedical Concept) accept no liability for any loss, injury, or damage of any kind arising directly or indirectly from use of, or reliance on, this content. Nothing in this notice excludes or limits any liability that cannot lawfully be excluded or limited.
Questions about this material can be directed to us via our contact page.
Last reviewed: November 16, 2026.